EPS for MEDNAX Inc (MD) Expected At $0.79

October 12, 2017 - By Kurt Siggers

 EPS for MEDNAX Inc (MD) Expected At $0.79

Investors wait MEDNAX Inc (NYSE:MD) to report on October, 26. its quarterly earnings Wall Street analysts expect $0.79 EPS, down $0.28 or 26.17 % from last year’s $1.07 same quarter earnings. This translates into $74.57M profit for MD giving the stock a 13.48 P/E. This is assuming the current $0.79 EPS is accurate. MEDNAX Inc’s Wall Street analysts see -1.25 % negative EPS growth, taking into account the $0.80 EPS reproted in the previous quarter, About 1.01 million shares traded. MEDNAX Inc (NYSE:MD) has declined 18.20% since October 13, 2016 and is downtrending. It has underperformed by 34.90% the S&P500.

MEDNAX Inc (NYSE:MD) Ratings Coverage

Among 14 analysts covering MEDNAX (NYSE:MD), 3 have Buy rating, 1 Sell and 10 Hold. Therefore 21% are positive. MEDNAX had 34 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of MEDNAX Inc (NYSE:MD) earned “Overweight” rating by JP Morgan on Wednesday, September 16. The firm has “Neutral” rating by Mizuho given on Tuesday, May 30. The firm has “Hold” rating given on Monday, June 5 by Jefferies. On Tuesday, August 25 the stock rating was maintained by Stifel Nicolaus with “Buy”. The company was downgraded on Friday, May 5 by Bank of America. The firm has “Hold” rating given on Thursday, August 31 by Jefferies. The rating was downgraded by Susquehanna to “Neutral” on Monday, March 7. As per Friday, September 1, the company rating was maintained by Robert W. Baird. Citigroup maintained MEDNAX Inc (NYSE:MD) rating on Wednesday, August 17. Citigroup has “Neutral” rating and $72 target. Jefferies maintained MEDNAX Inc (NYSE:MD) rating on Friday, August 26. Jefferies has “Buy” rating and $75 target.

MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The company has market cap of $4.02 billion. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital neonatal intensive care units , to babies born prematurely or with medical complications. It has a 13.59 P/E ratio. As of December 31, 2016, the Company had over 1,390 affiliated physicians providing anesthesia care to patients in connection with surgical and other procedures, as well as pain management.

More news for MEDNAX Inc (NYSE:MD) were recently published by: Businesswire.com, which released: “MEDNAX Addresses National Opioid Use and Abuse” on October 10, 2017. Businesswire.com‘s article titled: “MEDNAX Announces Acquisition of Leading Connecticut Radiology Practice” and published on September 28, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: